Islamabad: Davis Pharma marked another significant milestone in its journey of growth and innovation with the official launch of its new group, “Lifeline.” The grand launching ceremony was held in Islamabad, attended by the company’s top executives, officers, and staff members.
Addressing the ceremony, Group Head Umar Sharif highlighted the background, objectives, and future roadmap of the new group. He said that Davis Pharma has always prioritized innovation, research, and quality, and the creation of “Lifeline” signifies the beginning of a new chapter in the company’s progressive journey.
Manager Commercial, Growth & Strategy Arusa Zulfiqar gave an in-depth presentation on the structure, business strategy, and market potential of “Lifeline.” She emphasized that the new group will strengthen Davis Pharma’s market presence and play a vital role in achieving future growth goals.
The event was graced by Chief Executive Officer Amanullah Sheikh as the chief guest. In his remarks, he described the launch of “Lifeline” as a reflection of Davis Pharma’s commitment to advancement, public service, and alignment with modern healthcare needs. He reaffirmed the company’s mission to provide safe, effective, and reliable medicines to the public, noting that “Lifeline” will expand this vision further.
The ceremony concluded with participants congratulating the company’s leadership on the successful launch and extending best wishes for the continued success of the “Lifeline” group.
